Figure 5

![Figure 5: The relationship between gut microbiota composition and hyperlipidemia is outlined, showing microbial pathways involved in bile acid metabolism and cholesterol homeostasis. Probiotic interventions targeting these pathways are discussed.]()

> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)

<figure>
  <img src="" alt="The relationship between gut microbiota composition and hyperlipidemia is outlined, showing microbial pathways involved in bile acid metabolism and cholesterol homeostasis. Probiotic interventions targeting these pathways are discussed." />
  <figcaption>Figure 5. The relationship between gut microbiota composition and hyperlipidemia is outlined, showing microbial pathways involved in bile acid metabolism and cholesterol homeostasis. Probiotic interventions targeting these pathways are discussed.<br>  Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption>
</figure>